145 results on '"Brown, Robert A."'
Search Results
2. Advancing our standards: Do we need to standardize the use of nonstandard donor organs in patients with low MELD?
3. Precipitous changes in nomenclature and definitions—NAFLD becomes SLD: Implications for and expectations of AASLD journals
4. Affordable Care Act Medicaid expansion associated with increased liver transplant waitlist access without worsening mortality
5. Chasing equity: The evolving effects of MMaT-3 policy on outcomes of liver transplantation for hepatocellular carcinoma
6. Practice patterns of the medical evaluation of living liver donors in the United States
7. Hepatitis C and Liver Transplantation in the Era of New Antiviral Treatments
8. Black patients and women have reduced access to liver transplantation for alcohol‐associated liver disease
9. Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial
10. Deceased donor liver transplantation in patients on direct oral anticoagulants at the time of transplant surgery: A case series
11. Introducing the Certificate of Added Qualification ( CAQ ) Corner
12. The Dark Before Dawn
13. Practices and Perceptions of Living Donor Liver Transplantation, Nondirected Donation, and Liver Paired Exchange: A National Survey
14. A New Hope for a New Year
15. Protecting Patients With Cirrhosis From Coronavirus Disease 2019: Identifying Gaps in Vaccination Rates
16. Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection
17. Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network
18. The Level of Alcohol Consumption in the Prior Year Does Not Impact Clinical Outcomes in Patients With Alcohol‐Associated Hepatitis
19. Can Living Donor Liver Transplantation in the United States Reach Its Potential?
20. Medicaid Expansion Association With End‐Stage Liver Disease Mortality Depends on Leniency of Medicaid Hepatitis C Virus Coverage
21. The Current Management of Hepatorenal Syndrome–Acute Kidney Injury in the United States and the Potential of Terlipressin
22. Expanding the bounds of liver transplantation
23. Predictors of donor follow-up after living donor liver transplantation
24. The impact of left ventricular hypertrophy on survival in candidates for liver transplantation
25. Bland embolization versus chemoembolization of hepatocellular carcinoma before transplantation
26. Practices and Perceptions of Living Donor Liver Transplantation, Nondirected Donation, and Liver Paired Exchange: A National Survey.
27. A Review of the Current State of Liver Transplantation Disparities
28. Reply
29. National Trends in Location of Death in Patients With End‐Stage Liver Disease
30. A New Year, A New Team
31. Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues
32. Prevention of de novo hepatitis B with adefovir plus vaccination in recipients of liver transplants from core antibody–positive donors
33. Cholestatic hepatitis C following liver transplantation: An outcome-based histological definition, clinical predictors, and prognosis
34. Prevention of de novo hepatitis B with adefovir dipivoxil in recipients of liver grafts from hepatitis B core antibody–positive donors
35. Risk of advanced fibrosis with grafts from hepatitis C antibody–positive donors: A multicenter cohort study
36. Recipient-Donor race mismatch for African American liver transplant patients with chronic hepatitis C
37. Transdermal Rivastigmine for Treatment of Encephalopathy in Liver Cirrhosis - A Randomized Placebo Controlled Trial (TREC Trial).: Abstract# O-167
38. Prevention of De Novo Hepatitis B Infection with Adefovir Dipivoxil (ADV) Plus Vaccination in Liver Transplant Recipients of Hepatitis B Core Antibody Positive (HBcAb+) Donors.: Abstract# O-106
39. Effects of ethnicity and socioeconomic status on survival and severity of fibrosis in liver transplant recipients with hepatitis C virus#
40. The Dilemma of Adult-to-Adult Living Donor Liver Transplantation
41. A Randomized, Multicenter Study Comparing Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Recipients With Chronic Hepatitis C†
42. Toll-like receptor 2 polymorphism and gram-positive bacterial infections after liver transplantation
43. Spectrum of early-onset and late-onset bacteremias after liver transplantation: Implications for management
44. Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort studya,b,c
45. Role of Terlipressin and Albumin for Hepatorenal Syndrome in Liver Transplantation
46. The North American Consortium for the Study of End‐Stage Liver Disease–Acute‐on‐Chronic Liver Failure Score Accurately Predicts Survival: An External Validation Using a National Cohort
47. Health-related quality of life and survival in liver transplant candidates
48. Drivers of the cost of liver transplantation: Is it the donor, the recipient, or the center?1
49. Liver transplantation outcomes among Caucasians, Asian Americans, and African Americans with hepatitis B
50. Risk Factors and Impact of Chronic Obstructive Pulmonary Disease in Candidates for Liver Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.